- Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy. Smith, M.R., Manola, J., Kaufman, D.S., George, D., Oh, W.K., Mueller, E., Slovin, S., Spiegelman, B., Small, E., Kantoff, P.W. Cancer (2004)